LIR Life Sciences Corp. (SKNY.CN)
Canadian Sec · CAD · Healthcare · Biotechnology
CA$0.11 (-15.38%) as of
Key statistics
- Market cap
- 3.15M
- EPS (TTM)
- -0.1700
- Dividend yield
- 0.00%
- 52-week range
- 0.1000 – 2.4100
- Profit margin
- 0.00%
- Volume
- 78.63k
About LIR Life Sciences Corp.
LIR Life Sciences Corp. operates as biopharmaceutical company that develops transdermal delivery system through formulations of GLP-1 combination therapies for obesity and metabolic disorders. The company is based in Vancouver, Canada.
- Sector
- Healthcare
- Industry
- Biotechnology
- Headquarters
- Vancouver, BC, Canada
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.